---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-003432"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2022-01-12T23:59:59+00:00"
generated_at: "2026-06-27T18:37:41.357340+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Hepion Pharmaceuticals announces death of director Thomas Adams

## Summary
- Thomas Adams, Ph.D., passed away on January 9, 2022 due to natural causes.
- Dr. Adams served on Hepion's board since September 2016.
- No replacement director has been announced as of the press release date.
- Company expressed condolences; no other operational changes reported.

## SEC filing metadata
- accession: 0001104659-22-003432
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2022-01-12T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000110465922003432/0001104659-22-003432-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000110465922003432/tm222713d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-003432
- JSON: https://secwatch.observer/filing/0001104659-22-003432.json
- Plain text: https://secwatch.observer/filing/0001104659-22-003432.txt

## Key facts
- Executive change
  Tom Adams departed as Director at Hepion Pharmaceuticals, Inc..
  - Action: passed away
  - Role: Director
  source text: On January 9, 2022, Dr. Tom Adams, a director of Hepion Pharmaceuticals, Inc., passed away.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583771/000110465922003432/0001104659-22-003432-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.